Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alexandre Harlé

19PUBLICATIONS
28CO-AUTHORS
Cancer geneticsImmunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

Sort by Publication Date:
|Feb 06, 2026
Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Medina Kalimulaeva, Leen Van Langenhoven, Karen Leroy

|Jan 28, 2026
Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of <i>IDH</i> Variants in Solid Tumors and Hematological Malignancies.

Pauline Gilson, Marc Muller, Guillaume Gauchotte

|Dec 23, 2023
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS).

Jean-Louis Merlin, Marie Husson, Nassim Sahki

|Nov 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.

Rémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé

|Nov 14, 2023
<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

Margaux Betz, Vincent Massard, Pauline Gilson

|Oct 27, 2022
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.

Julie Egea, Julia Salleron, Sophie Gourgou

Pageof 4

Frequent Collaborators

6 joint publications

Andréa Witz

6 joint publications

Jean-Louis Merlin

5 joint publications

Pauline Gilson

3 joint publications

Aurélien Lambert

2 joint publications

Thierry Conroy

2 joint publications

Margaux Betz

2 joint publications

Julie Dardare

1 joint publications

Hélène Dumond

1 joint publications

Romain Boidot

1 joint publications

Julie Egea

Frequent Collaborators

6 joint publications

Andréa Witz

6 joint publications

Jean-Louis Merlin

5 joint publications

Pauline Gilson

3 joint publications

Aurélien Lambert

Top Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on : Jan 16, 2019

11.4K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

25.0K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on : Apr 11, 2016

11.9K
See more related videos

Top Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on : Jan 16, 2019

11.4K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

25.0K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on : Apr 11, 2016

11.9K
See more related videos